CBD Oil Market - 2024-2031

September 2024 | 33 pages | ID: CE7D398F267AEN
DataM Intelligence

US$ 3,400.00 US$ 4,350.00 -22 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
CBD Oil Market reached USD 20,822.1 million in 2031 and, growing with a CAGR of 18.67% during the forecast period 2031-2035.

The CBD Oil Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A CBD Oil Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Product
  • Original *
  • Blended
By Product Category
  • Unflavored *
  • Flavored
By Type
  • THC Dominant*
  • Marijuana Based
  • CBD Dominant
  • Hemp Based
By Category
  • Isolate CBD Oil *
  • Full Spectrum CBD Oil
  • Broad Spectrum CBD Oil
By Application
  • Pharma & Nutraceuticals *
  • Food and Beverages
  • Personal Care and Cosmetics
  • Others
By Distribution Channel
  • Pharma Retail Store*
  • E-Commerce
  • Hospital Pharma Retail
  • Others
Regional Analysis for CBD Oil Market:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
  • Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
  • South America (Colombia, Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
This Report Covers:
  • Go-to-market Strategy.
  • Neutral perspective on the market performance.
  • Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
  • Customized regional/country reports as per request and country level analysis.
  • Potential & niche segments and regions exhibiting promising growth covered.
  • Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Research Process:

Both primary and secondary data sources have been used in the global CBD Oil Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Product
3.2. Snippet by Product Category
3.3. Snippet by Type
3.4. Snippet by Category
3.5. Snippet by Application
3.6. Snippet by Distribution Channel
3.7. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
  4.1.2. Restraints
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 ANALYSIS

6.1. Analysis of COVID-19
  6.1.1. Before COVID-19 Scenario
  6.1.2. Present COVID-19 Scenario
  6.1.3. Post COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. BY PRODUCT

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  7.1.2. Market Attractiveness Index, By Product
7.2. Original *
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Blended

8. BY PRODUCT CATEGORY

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Category
  8.1.2. Market Attractiveness Index, By Product Category
8.2. Unflavored *
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Flavored

9. BY TYPE

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  9.1.2. Market Attractiveness Index, By Type
9.2. THC Dominant*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Marijuana Based
9.4. CBD Dominant
9.5. Hemp Based

10. BY CATEGORY

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
  10.1.2. Market Attractiveness Index, By Category
10.2. Isolate CBD Oil *
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Full Spectrum CBD Oil
10.4. Broad Spectrum CBD Oil

11. BY APPLICATION

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  11.1.2. Market Attractiveness Index, By Application
11.2. Pharma & Nutraceuticals *
  11.2.1. Introduction
  11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Food and Beverages
11.4. Personal Care and Cosmetics
11.5. Others

12. BY DISTRIBUTION CHANNEL

12.1. Introduction
  12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  12.1.2. Market Attractiveness Index, By Distribution Channel
12.2. Pharma Retail Store*
  12.2.1. Introduction
  12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. E-Commerce
12.4. Hospital Pharma Retail
12.5. Others

13. BY REGION

13.1. Introduction
  13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  13.1.2. Market Attractiveness Index, By Region
13.2. North America
  13.2.1. Introduction
  13.2.2. Key Region-Specific Dynamics
  13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Category
  13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
  13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  13.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.2.9.1. The U.S.
    13.2.9.2. Canada
    13.2.9.3. Mexico
13.3. Europe
  13.3.1. Introduction
  13.3.2. Key Region-Specific Dynamics
  13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Category
  13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
  13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  13.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.3.9.1. Germany
    13.3.9.2. The U.K.
    13.3.9.3. France
    13.3.9.4. Italy
    13.3.9.5. Spain
    13.3.9.6. Rest of Europe
13.4. South America
  13.4.1. Introduction
  13.4.2. Key Region-Specific Dynamics
  13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Category
  13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
  13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  13.4.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.4.9.1. Brazil
    13.4.9.2. Argentina
    13.4.9.3. Rest of South America
13.5. Asia-Pacific
  13.5.1. Introduction
  13.5.2. Key Region-Specific Dynamics
  13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Category
  13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
  13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  13.5.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.5.9.1. China
    13.5.9.2. India
    13.5.9.3. Japan
    13.5.9.4. Australia
    13.5.9.5. Rest of Asia-Pacific
13.6. Middle East and Africa
  13.6.1. Introduction
  13.6.2. Key Region-Specific Dynamics
  13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Category
  13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Category
  13.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

14. COMPETITIVE LANDSCAPE

14.1. Competitive Scenario
14.2. Market Positioning/Share Analysis
14.3. Mergers and Acquisitions Analysis

15. COMPANY PROFILES

15.1. Medical Marijuana*
  15.1.1. Company Overview
  15.1.2. Grade Portfolio and Description
  15.1.3. Financial Overview
  15.1.4. Key Developments
15.2. NuLeaf Naturals
15.3. Aurora Cannabis
15.4. Gaia Herbs
15.5. ENDOCA
15.6. Diamond CBD
15.7. FOLIUM BIOSCIENCES
15.8. CV Sciences, Inc
15.9. ConnOils LLC
15.10. IrieCBD
15.11. PureKana
15.12. CBD American Shaman
15.13. Canopy Growth
15.14. Elixinol Global Limited
15.15. Kazmira(*LIST NOT EXHAUSTIVE)

16. APPENDIX

16.1. About Us and Services
16.2. Contact Us


More Publications